Have a feature idea you'd love to see implemented? Let us know!
Back to ADMA overview

ADMA Adma Biologics PE ratio, current and historical analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: ADMA
  4. PE Ratio

As of Jan 21, 2025, the Adma Biologics stock's PE ratio is 55.72. This takes into account the latest EPS of $0.29 and stock price of $16.16.

ADMA PE ratio history

How has ADMA's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Adma Biologics PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

ADMA average PE ratio chart

What is the average PE ratio of ADMA for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

ADMA PE vs peers

What is ADMA's PE ratio compared to its peers
Stock name PE ratio Market cap
ADMA Adma Biologics Inc 55.52 $3.81B
NVAX Novavax Inc N/A $1.43B
RGEN Repligen Corp N/A $9.49B
CVM Cel Sci Corp N/A $29.58M

Frequently asked questions

What is Adma Biologics's PE ratio?

ADMA's price to earnings ratio is 55.72 as of Jan 21, 2025.

How is ADMA's PE ratio calculated (Adma Biologics PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jan 21, 2025), Adma Biologics's share price is $16.16. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.29. Therefore, Adma Biologics's PE ratio for today is 55.72. PE RATIO(55.72) = STOCK PRICE($16.16) / TTM EPS($0.29)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.